WELCOME

Dear Colleagues,

We are pleased to invite you to participate in the Vth  Sechenov International Biomedical Summit 2021 (SIBS-2021). Organized and hosted by the Sechenov University, the hybrid event will take place on November 9-10, 2021.

Access to all sessions of the summit will be available through the participant's Personal Account.

SIBS-2021 is an event of great current relevance and interest. It will provide an inspiring program, covering a wide spectrum of topics in the field of digital and practical developments in biomedicine and applied technologies.

Sessions will be devoted to such areas and approaches as biodesign, digital oncology, multiomics, medical elementology in cardiology and oncology, digital cardiology, microfluidics and mathematical modeling, molecular oncology and targeted drug delivery, and other.

The summit will include scientific symposia, schools of young scientists, master classes and round tables, at which presentations of leading Russian and world scientists will be presented.

About 300 specialists are traditionally expected at the event: geneticists, pharmacologists, personalized medicine doctors, experts in the field of cell and gene therapy, tissue engineering and regenerative medicine.

The exhibition is an important part of the summit. Participants will be able to learn about the latest achievements of the leading Russian and world manufacturing companies in the field of biomedicine and pharmacology. Being part of SIBS-2021, the exhibition will also be held in a hybrid format.

The working language of the summit is English. Simultaneous translation will be provided for selected sessions.

We hope that the participants of the event will establish new contacts for future joint projects, present their concepts and discuss the possibilities of effective cooperation.

Many thanks and appreciation to all speakers who agreed to deliver theirs presentations and share knowledge and experience.

Sincerely,
Organizing Committee
Vth Sechenov International
Biomedical Summit 2021
(SIBS-2021)